BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24796111)

  • 1. A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk.
    Li R; Miao L; Qin L; Xiang Y; Zhang X; Peng H; Mailamuguli ; Sun Y; Yao H
    Int J Clin Exp Pathol; 2015; 8(9):9812-23. PubMed ID: 26617691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
    Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
    Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack.
    Zhao T; Cao L; Lin C; Xu R; Du X; Zhou M; Yang X; Wan W; Zou H; Zhu X
    Rheumatology (Oxford); 2023 Dec; 62(12):3984-3992. PubMed ID: 37042723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG transporters and disease.
    Woodward OM; Köttgen A; Köttgen M
    FEBS J; 2011 Sep; 278(18):3215-25. PubMed ID: 21554546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Association of Rare Allelic Variants in Urate Transporters
    Vávra J; Pavelcová K; Mašínová J; Hasíková L; Bubeníková E; Urbanová A; Mančíková A; Stibůrková B
    Dis Markers; 2024; 2024():5930566. PubMed ID: 38222853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urate Handling in the Human Body.
    Hyndman D; Liu S; Miner JN
    Curr Rheumatol Rep; 2016 Jun; 18(6):34. PubMed ID: 27105641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target Screen of Anti-Hyperuricemia Compounds from Cortex Fraxini In Vivo Based on ABCG2 and Bioaffinity Ultrafiltration Mass Spectrometry.
    Huang X; Dong W; Luo X; Xu L; Wang Y
    Molecules; 2023 Dec; 28(23):. PubMed ID: 38067624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alistipes indistinctus-derived hippuric acid promotes intestinal urate excretion to alleviate hyperuricemia.
    Xu YX; Liu LD; Zhu JY; Zhu SS; Ye BQ; Yang JL; Huang JY; Huang ZH; You Y; Li WK; He JL; Xia M; Liu Y
    Cell Host Microbe; 2024 Mar; 32(3):366-381.e9. PubMed ID: 38412863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter.
    Sun X; Yang L; Sun H; Sun Y; Wei S; Han Y; Wang W; Kong L; Wang X
    Front Pharmacol; 2023; 14():1275974. PubMed ID: 38094893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of urate transport in the nephrons in subtypes of hyperuricemia.
    Nakamura T; Nishi R; Tanaka T; Takagi K; Sakai K; Takai M; Morishima S; Yamauchi T; Ueda T
    Nephron Extra; 2013; 3(1):73-85. PubMed ID: 24052801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased extra-renal urate excretion is a common cause of hyperuricemia.
    Ichida K; Matsuo H; Takada T; Nakayama A; Murakami K; Shimizu T; Yamanashi Y; Kasuga H; Nakashima H; Nakamura T; Takada Y; Kawamura Y; Inoue H; Okada C; Utsumi Y; Ikebuchi Y; Ito K; Nakamura M; Shinohara Y; Hosoyamada M; Sakurai Y; Shinomiya N; Hosoya T; Suzuki H
    Nat Commun; 2012 Apr; 3():764. PubMed ID: 22473008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCG2/BCRP dysfunction as a major cause of gout.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
    Eckenstaler R; Benndorf RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress and prospects for research on urate efflux transporter ABCG2].
    Ichida K
    Nihon Rinsho; 2014 Apr; 72(4):757-65. PubMed ID: 24796111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.